在精神分裂症患者和健康志愿者中对catecholamine耗尽的行为反应
Samir Suker1, Yoan Mihov2, Andreas Wolf1
1Psychiatric University Hospital, University of Bern, Bern, Switzerland.
Schizophrenia bulletin open
|August 15, 2024
概括
急性多巴胺消耗暂时减少了精神分裂症患者的妄想和思维障碍. 这表明多巴胺.
科学领域:
- 神经科学是一个神经科学.
- 精神病学是一个精神病学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 精神分裂症与多巴胺系统功能障碍有关.
- 异常突出理论提出妄想是由于多巴胺信号的改变而产生的.
- 这项研究调查了多巴胺缺乏对精神分裂症症状和突出性归因的影响.
研究的目的:
- 为了测试多巴胺的精神分裂症的假设,使用catecholamine耗尽.
- 为了检查急性多巴胺耗尽是否改善精神分裂症的积极症状和突出性归因.
- 通过突出归因来探索多巴胺在调解妄想中的作用.
主要方法:
- 随机,双盲,安慰剂控制的交叉试验.随机,双盲,安慰剂控制的交叉试验.
- 使用阿尔法甲基-氨酸 (AMPT) 治疗甲基胺缺乏症.
- 评估了15名精神分裂症患者和15名健康对照人群,使用症状和突出性归因尺度.
主要成果:
- 在精神分裂症患者 (P = .013,P = .010) 中,catecholamine耗尽暂时减少了妄想和积极的正式思维障碍.
- 趋势表明,多巴胺耗尽增加了精神分裂症患者的相关偏差和适应突出性,同时在对照组中降低了这些偏差和适应性突出性 (P = .060,P = .089).
- 降低了精神分裂症患者的幻觉症状与AMPT治疗后更高的相关偏差相关 (rho = -0.761,P = .001).
结论:
- 多巴胺过度活跃与精神分裂症妄想的联系可能是由受损的突出性归因介导的.
- 急性多巴胺耗尽为特定精神病症状提供了潜在的治疗途径.
- 这些发现支持了精神分裂症错觉的异常突出模型.
更多相关视频
07:02A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development
Published on: February 11, 2019
9.8K
05:52Handwriting Analysis Indicates Spontaneous Dyskinesias in Neuroleptic Naïve Adolescents at High Risk for Psychosis
Published on: November 21, 2013
14.9K
相关概念视频
01:21Drugs Affecting Neurotransmitter Release or Uptake
1.0K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.0K
01:25Adrenergic Agonists: Indirect-Acting Agents
1.5K
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
1.5K
01:28Adrenergic Agonists: Mixed-Action Agents
691
Mixed-action adrenergic agonists, like ephedrine and pseudoephedrine, directly and indirectly affect adrenergic receptors. These agents stimulate adrenoceptors and indirectly release stored neurotransmitters, amplifying the adrenergic response.
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
691
01:30Adrenergic Agonists: Therapeutic Uses
756
Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
756
01:30Negative and Cognitive Symptoms of Schizophrenia
46
Negative symptoms of schizophrenia indicate a reduction or absence of typical behaviors and emotional responses found in healthy individuals, while positive symptoms reflect an excess or distortion of normal functioning.
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
46
01:27Adrenergic Neurons: Neurotransmission
3.5K
Postganglionic sympathetic fibers (except those supplying the sweat glands) releasing noradrenaline or norepinephrine are called noradrenergic or adrenergic neurons. Noradrenaline, dopamine, adrenaline, or epinephrine are collectively called "catecholamines" as they contain a catechol moiety and an amine side chain. The five stages of neurotransmitter release involve their synthesis, storage, release, reuptake and metabolism.
Synthesis: Catecholamine synthesis requires tyrosine, which...
Synthesis: Catecholamine synthesis requires tyrosine, which...
3.5K